Frontiers in Psychiatry | Psychopharmacology

Brief Research Report

Published on 10 May 2024

Hype or hope? Ketamine for the treatment of depression: results from the application of deep learning to Twitter posts from 2010 to 2023

in Psychopharmacology

Qin Xiang Ng
Yu Liang Lim
Clarence Ong
Silas New
Johnson Fam
Tau Ming Liew

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1369727

2,904 views
3 citations

Editorial

Published on 06 May 2024

Editorial: Psychotropic overprescribing to youth: scope of the problem, causes, and possible solutions

in Psychopharmacology

Jennifer L. McLaren
Julie M. Zito
Jörg M. Fegert
Erin R. Barnett

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1418600

3,882 views

Case Report

Published on 29 Apr 2024

Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction

in Psychopharmacology

Florine M. Wiss
Samuel S. Allemann
Henriette E. Meyer zu Schwabedissen
Céline K. Stäuble
Thorsten Mikoteit
Markus L. Lampert

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1397876

3,844 views
1 citation

Case Report

Published on 26 Apr 2024

Case report: Escitalopram-associated lower limb edema

in Psychopharmacology

Mohamed Hassan Ahmed
Mena Al-Kubaisi
Safa Abdulmajeed Al-Rawi
Omar Hosam Salama
Hebah Mahmoud Abutayyem

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1394813

6,624 views
1 citation

Perspective

Published on 18 Apr 2024

Psychiatric and legal considerations for ketamine treatment within prison settings

in Psychopharmacology

Michael Bayrhammer-Savel
Martin Ortner
Marie-Claire Van Hout
Arkadiusz Komorowski

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1316108

2,728 views
5 citations

Original Research

Published on 18 Apr 2024

Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distress

in Psychopharmacology

Julia Ruixi Wang
Samuel J. Mendez Araque
Gina Micciche
Andrew McMillan
Emily Coughlin
Rosalie Mattiola
Diana English
Kristopher Kaliebe

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1301960

4,963 views
3 citations

Original Research

Published on 10 Apr 2024

Long-term benefits to psychological health and well-being after ceremonial use of Ayahuasca in Middle Eastern and North African immigrants and refugees

in Psychopharmacology

Matthew X. Lowe
Hannes Kettner
Del R. P. Jolly
Robin L. Carhart-Harris
Heather Jackson

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1279887

8,125 views
4 citations

Original Research

Published on 09 Apr 2024

Reduced prevalence of drug-related problems in psychiatric inpatients after implementation of a pharmacist-supported computerized physician order entry system - a retrospective cohort study

in Psychopharmacology

Katharina Wien
Julia Thern
Anika Neubert
Britta-Lena Matthiessen
Stefan Borgwardt

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1304844

3,205 views
5 citations

Original Research

Published on 04 Apr 2024

Effects of systemic pretreatment with the NAALADase inhibitor 2-PMPA on oral methamphetamine reinforcement in C57BL/6J mice

in Psychopharmacology

Elissa K. Fultz
Andrea Y. T. Nei
Joyce C. Chi
Jacqueline N. Lichter
Karen K. Szumlinski

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1297275

1,716 views
1 citation

Original Research

Published on 03 Apr 2024

Serious adverse drug events associated with psychotropic treatment of bipolar or schizoaffective disorder: a 17-year follow-up on the LiSIE retrospective cohort study

in Psychopharmacology

Petra Truedson
Michael Ott
Lisa Wahlström
Robert Lundqvist
Martin Maripuu
Krister Lindmark
Ingrid Lieber
Ursula Werneke

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1358461

3,227 views
2 citations

General Commentary

Published on 25 Mar 2024

Commentary: Perspectives on ADHD in children and adolescents as a social construct amidst rising prevalence of diagnosis and medication use

in Psychopharmacology

Tycho J. Dekkers

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1383492

4,967 views
3 citations

Case Report

Published on 19 Mar 2024

Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics

in Psychopharmacology

Liam Korošec Hudnik
Tanja Blagus
Sara Redenšek Trampuž
Vita Dolžan
Jurij Bon
Milica Pjevac

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1363051

4,635 views
5 citations

Systematic Review

Published on 08 Mar 2024

Hype or hope? High placebo response in major depression treatment with ketamine and esketamine: a systematic review and meta-analysis

in Psychopharmacology

Alexandros Matsingos
Marcel Wilhelm
Laila Noor
Cüneyt Yildiz
Winfried Rief
Stefan G. Hofmann
Irina Falkenberg
Tilo Kircher

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1346697

7,001 views
14 citations

Editorial

Published on 28 Feb 2024

Editorial: Reviews in psychiatry 2022: psychopharmacology

in Psychopharmacology

Maris Taube

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1382027

1,949 views

Original Research

Published on 22 Feb 2024

Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey

in Psychopharmacology

Nicolas G. Glynos
Jacob S. Aday
Daniel Kruger
Kevin F. Boehnke
Stephanie Lake
Philippe Lucas

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1349565

7,226 views
8 citations

Case Report

Published on 20 Feb 2024

Case report: Adult with bipolar disorder and autism treated with ketamine assisted psychotherapy

in Psychopharmacology

Christopher P. Harris
Becky Jones
Kathryn Walker
Meredith S. Berry

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1322679

7,403 views